KELUN

Kelun is a highly specialized innovative pharmaceutical group with annual sales revenue of over RMB 40 billion, including more than 100 enterprises at home and abroad, such as Sichuan Kelun Pharmaceutical Co., Ltd, Sichuan Kelun Pharmaceutical Research Institute Co., Ltd., Klus Pharma Inc. (Kelun, USA), KELUN-Kazpharm LLP (Kelun-Kazpharm) and Sichuan Kelun Medicine & Trade Group Co., Ltd., etc. In 2017, Kelun ranked 155th in China's top 500 manufacturing enterprises. In 2018, Kelun was awarded as Manufacturing Individual Champion Demonstration Enterprise by virtue of its global advantages in large volume injections. In 2022, Kelun ranked among the Top 3 in Chinese pharmaceutical manufacturing industry... In the field of IV solution, Kelun has achieved comprehensive industrial upgrading by driving profitability through high-end manufacturing and new materials , and possesses the strategic advantages of technical innovations and quality benchmarks. Kelun has established a closed..

Also known as: KELUN-Kazpharm, KELUN-Kazpharm LLP

Primary location: Chengdu China